Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
AB-729, a GalNAc-siRNA, results in robust reductions of HBV DNA and HBsAg in subjects with chronic hepatitis B infection Proceeding/Conference:Hepatology International | 2021 | ||
Safety and pharmacodynamics of the GALNAC-siRNA AB-729 in subjects with chronic hepatitis B infection Proceeding/Conference:Hepatology | 2020 |